Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	57622
Country	Türkiye

Received	2020-06-17 09:01
Peer-Review Started	2020-06-17 09:02
To Make the First Decision
Return for Revision	2020-07-04 21:35
Revised	2020-07-07 21:31
Second Decision	2020-09-22 11:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-09-22 20:15
Articles in Press	2020-09-22 20:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-10-08 02:40
Publish the Manuscript Online	2020-10-14 13:53

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
Manuscript Source	Invited Manuscript
All Author List	Ozkan Kanat, Hulya Ertas and Burcu Caner
ORCID	Author(s) ORCID Number Ozkan Kanat http://orcid.org/0000-0001-6973-6540 Hulya Ertas http://orcid.org/0000-0001-8306-4349 Burcu Caner http://orcid.org/0000-0003-1591-3323
Funding Agency and Grant Number
Corresponding Author	Ozkan Kanat, MD, PhD, Professor, Department of Medical Oncology, Acıbadem Bursa Hospital, Fatih Sultan Mehmet Street, Bursa 16059, Türkiye. ozkanat@uludag.edu.tr
Key Words	BRAF mutation; V600 mutations; Metastatic colorectal cancer; Targeted therapies; ;
Core Tip	The treatment of BRAF-mutant metastatic colorectal cancer is particularly challenging. This review discusses the current treatment options for BRAF-mutant metastatic colorectal cancer and the expanding role of targeted therapy in its management.
Publish Date	2020-10-14 13:53
Citation	Kanat O, Ertas H, Caner B. Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations. World J Gastrointest Oncol 2020; 12(10): 1080-1090
URL	https://www.wjgnet.com/1948-5204/full/v12/i10/1080.htm
DOI	https://dx.doi.org/10.4251/wjgo.v12.i10.1080

Full Article (PDF)	WJGO-12-1080.pdf
Full Article (Word)	WJGO-12-1080.docx
Manuscript File	57622-Review.docx
Answering Reviewers	57622-Answering reviewers.pdf
Audio Core Tip	57622-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	57622-Conflict-of-interest statement.pdf
Copyright License Agreement	57622-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	57622-Language certificate.pdf
Peer-review Report	57622-Peer-review(s).pdf
Scientific Misconduct Check	57622-Bing-Yan JP-1.png
Scientific Misconduct Check	57622-Scientific misconduct check.pdf
Scientific Editor Work List	57622-Scientific editor work list.pdf